A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical modelsEric S. Lightcap, Dennis Huszar, Erik Koenig et al.|Science Translational Medicine|2021Cited by 139
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancerZhen Lu, Serge Y. Fuchs|Nature Communications|2022Cited by 33
Regulation of intercellular biomolecule transfer–driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Serge Y. Fuchs|Journal of Clinical Investigation|2021Cited by 20
Trogocytosis of cancer-associated fibroblasts promotes pancreatic cancer growth and immune suppression via phospholipid scramblase anoctamin 6 (ANO6)Charline Ogier, Igor Astsaturov, Charles Solomon Akino Mercy et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 18
Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activitiesZhen Lu, Serge Y. Fuchs|Cancer Immunology Immunotherapy|2022Cited by 12